219 related articles for article (PubMed ID: 2896387)
1. ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis.
Black WJ; Munoz JJ; Peacock MG; Schad PA; Cowell JL; Burchall JJ; Lim M; Kent A; Steinman L; Falkow S
Science; 1988 Apr; 240(4852):656-9. PubMed ID: 2896387
[TBL] [Abstract][Full Text] [Related]
2. Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.
Lobet Y; Feron C; Dequesne G; Simoen E; Hauser P; Locht C
J Exp Med; 1993 Jan; 177(1):79-87. PubMed ID: 8418210
[TBL] [Abstract][Full Text] [Related]
3. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.
Alonso S; Pethe K; Mielcarek N; Raze D; Locht C
Infect Immun; 2001 Oct; 69(10):6038-43. PubMed ID: 11553541
[TBL] [Abstract][Full Text] [Related]
4. Expression of pertussis toxin correlates with pathogenesis in Bordetella species.
Monack D; Munoz JJ; Peacock MG; Black WJ; Falkow S
J Infect Dis; 1989 Feb; 159(2):205-10. PubMed ID: 2464653
[TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.
Burnette WN; Cieplak W; Mar VL; Kaljot KT; Sato H; Keith JM
Science; 1988 Oct; 242(4875):72-4. PubMed ID: 2459776
[TBL] [Abstract][Full Text] [Related]
6. Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.
Nencioni L; Pizza M; Bugnoli M; De Magistris T; Di Tommaso A; Giovannoni F; Manetti R; Marsili I; Matteucci G; Nucci D
Infect Immun; 1990 May; 58(5):1308-15. PubMed ID: 2323818
[TBL] [Abstract][Full Text] [Related]
7. Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.
Kimura A; Mountzouros KT; Schad PA; Cieplak W; Cowell JL
Infect Immun; 1990 Oct; 58(10):3337-47. PubMed ID: 2119344
[TBL] [Abstract][Full Text] [Related]
8. Purification and immunological characterization of HPLC-purified pertussis toxin subunits.
Chong P; Cockle S; Boux H; Klein M
Biochem Cell Biol; 1991; 69(5-6):336-40. PubMed ID: 1654940
[TBL] [Abstract][Full Text] [Related]
9. Alkylation of cysteine 41, but not cysteine 200, decreases the ADP-ribosyltransferase activity of the S1 subunit of pertussis toxin.
Kaslow HR; Schlotterbeck JD; Mar VL; Burnette WN
J Biol Chem; 1989 Apr; 264(11):6386-90. PubMed ID: 2703495
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of genetically inactivated pertussis toxin.
Brown DR; Keith JM; Sato H; Sato Y
Dev Biol Stand; 1991; 73():63-73. PubMed ID: 1778335
[TBL] [Abstract][Full Text] [Related]
11. Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity.
Pizza M; Bartoloni A; Prugnola A; Silvestri S; Rappuoli R
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7521-5. PubMed ID: 2902632
[TBL] [Abstract][Full Text] [Related]
12. ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin.
Barbieri JT; Cortina G
Infect Immun; 1988 Aug; 56(8):1934-41. PubMed ID: 3135265
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity analysis of the activation of pertussis toxin.
Kaslow HR; Lim LK; Moss J; Lesikar DD
Biochemistry; 1987 Jan; 26(1):123-7. PubMed ID: 3030399
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mutant strains producing pertussis toxin cross reacting materials.
Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
[TBL] [Abstract][Full Text] [Related]
15. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
16. Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.
Burnette WN
Behring Inst Mitt; 1997 Feb; (98):434-41. PubMed ID: 9382767
[TBL] [Abstract][Full Text] [Related]
17. Investigating pertussis toxin and its impact on vaccination.
Coutte L; Locht C
Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
[TBL] [Abstract][Full Text] [Related]
18. Effects of mutations on enzyme activity and immunoreactivity of the S1 subunit of pertussis toxin.
Lobet Y; Cieplak W; Smith SG; Keith JM
Infect Immun; 1989 Nov; 57(11):3660-2. PubMed ID: 2807541
[TBL] [Abstract][Full Text] [Related]
19. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
[TBL] [Abstract][Full Text] [Related]
20. [Application of DNA microcarriers for evaluation of mice splenocytes genes expression after immunization with pertussis vaccines and challenged with different B. pertussis strains].
Gzyl A; Woyciechowska-Oczko M; Jarzab B; Augustynowicz E; Mosiej E; Slusarczyk J
Med Dosw Mikrobiol; 2007; 59(2):149-59. PubMed ID: 17929412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
